Bioxyne Ltd
ASX:BXN

Watchlist Manager
Bioxyne Ltd Logo
Bioxyne Ltd
ASX:BXN
Watchlist
Price: 0.041 AUD 5.13% Market Closed
Market Cap: AU$89.8m

Operating Margin

14.2%
Current
Improving
by 29%
vs 3-y average of -14.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.2%
=
Operating Income
AU$4m
/
Revenue
AU$28.4m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.2%
=
Operating Income
AU$4m
/
Revenue
AU$28.4m

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Bioxyne Ltd
ASX:BXN
88.8m AUD
Loading...
FR
L'Oreal SA
PAR:OR
203.9B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
117.4B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR
Loading...
UK
HALEON PLC
LSE:HLN
33.5B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
41.5B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.5B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
895.7B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Higher than 82% of companies in Australia
Percentile
82st
Based on 3 951 companies
82st percentile
14.2%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Bioxyne Ltd
Glance View

Market Cap
89.8m AUD
Industry
Consumer products

Bioxyne Ltd. engages in the research, development, market and distribution of health products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-12-14. The firm is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The firm operates through two segments wholesale sales and direct sales. The firm manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The firm is focusing on developing a range of functional food and beauty products.

BXN Intrinsic Value
0.06 AUD
Undervaluation 32%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
14.2%
=
Operating Income
AU$4m
/
Revenue
AU$28.4m
What is Bioxyne Ltd's current Operating Margin?

The current Operating Margin for Bioxyne Ltd is 14.2%, which is above its 3-year median of -14.8%.

How has Operating Margin changed over time?

Over the last 3 years, Bioxyne Ltd’s Operating Margin has increased from -98% to 14.2%. During this period, it reached a low of -98% on Jun 30, 2022 and a high of 14.2% on Jun 30, 2025.

Back to Top